CaM (calmodulin) has been implicated in the regulation of IP 3 R [IP 3 (inositol 1,4,5-trisphosphate) receptors] and a recent report suggested that CaM tightly tethered to IP 3 R was essential for IP 3 R activation [Nadif Kasri, Torok, Galione, Garnham, Callewaert, Missiaen, Parys and De Smedt (2006) J. Biol. Chem. 281, 8332-8338]. In the present study, we confirm that a CaM-binding peptide derived from MLCK (myosin light chain kinase) inhibits IP 3 -evoked Ca 2+ release via all three IP 3 R subtypes. However, inhibition by MLCK peptide is not mimicked by other CaM antagonists that effectively block regulation of IP 3 R by CaM. Inhibition by MLCK peptide is rapid, fully reversible and occurs under conditions where there is no CaM associated with IP 3 R. MLCK peptide stimulates IP 3 binding to IP 3 R1 and to its bacterially expressed N-terminal, but not after removal of the suppressor domain (residues 1-224). We suggest that MLCK peptide mimics a sequence within the suppressor domain that is similar to a 1-8-14 CaM-binding motif. The peptide may thereby unzip an interdomain interaction that is essential for IP 3 R activation. We conclude that CaM is not essential for IP 3 R activation, and that MLCK peptide is a selective antagonist of the IP 3 R that binds directly to the N-terminal to uncouple IP 3 binding from channel gating. The results of the present study highlight the importance of the suppressor domain in IP 3 R activation and suggest that MLCK peptide may provide a route to novel non-competitive antagonists of IP 3 R.
INTRODUCTION
IP 3 Rs [IP 3 (inositol 1,4,5-trisphosphate) receptors] are ubiquitously expressed intracellular Ca 2+ channels [1] [2] [3] . They mediate both the initial release of Ca 2+ from intracellular stores evoked by receptors that stimulate IP 3 formation and the regenerative propagation of intracellular Ca 2+ signals [4] . The latter depends upon Ca 2+ regulating the gating of IP 3 R. Indeed, even IP 3 works by regulating the Ca 2+ sensitivity of IP 3 R [2, 5] . The ability of Ca 2+ to both stimulate and inhibit IP 3 R is an important feature of all three vertebrate IP 3 R subtypes, but the structural basis of the Ca 2+ regulation is unresolved. There are several cytosolic Ca 2+ -binding sites within the IP 3 R itself [6] , but their physiological roles are undefined. A likely endogenous Ca 2+ -sensor lies within the central regulatory domain of the IP 3 R and includes a highly conserved glutamate residue (Glu 2100 in IP 3 R1), mutation of which affects the sensitivity to Ca 2+ [7] [8] [9] . Ca 2+ -binding sites within the N-terminal have also been implicated in Ca 2+ regulation of IP 3 R [6, 10] . The effects of Ca 2+ on IP 3 R might also be mediated by accessory proteins [11] . CaM (calmodulin), a ubiquitous intracellular Ca 2+ -sensor, was proposed to mediate Ca 2+ inhibition of IP 3 R [12] , but the evidence is conflicting [2, 11, 13] . In the presence of Ca 2+ , CaM inhibits IP 3 -evoked Ca 2+ release via each of the three IP 3 R subtypes [14] , but the inhibition does not require binding of Ca 2+ to CaM [15] . CaM is unlikely therefore to provide a Ca 2+ -sensor for the IP 3 R, but Ca 2+ -evoked changes in the IP 3 R may facilitate its interaction with CaM and thereby lead to inhibition.
Ca
2+ -CaM binds to a central site in IP 3 R1 and IP 3 R2 [16] [17] [18] (Figure 1A ), but the consequences are unclear because a mutation (W1577A) that eliminates Ca 2+ -CaM binding affects inhibition of IP 3 R1 function by neither Ca 2+ nor CaM [19, 20] . An additional Ca 2+ -CaM-binding site is unmasked after removal of the S2 splice site ( Figure 1A ) [17] , but it is unlikely to underlie the effects of CaM after mutation of W1577A because mutant IP 3 R with the S2 site respond normally [19, 20] . CaM also binds, in a Ca 2+ -independent manner to IP 3 R1 to cause inhibition of IP 3 binding [18, 21] . CaM or CaM 1234 likewise cause Ca 2+ -independent inhibition of IP 3 binding to an N-terminal fragment of IP 3 R1 (residues 1-582) [22, 23] . Within this N-terminal sequence, CaM binding straddles two regions (residues 50-82 and 107-129 of rat IP 3 R1) [10] ( Figure 1A ). The first of these sites also binds CaBP1 (calcium-binding protein 1) [24, 25] . Although the C-terminal region (residues 1565-1586) of the central CaMbinding site binds only Ca 2+ -CaM, additional N-terminal residues (1555-1586) allow it also to bind apo-CaM [14, 15] . The roles of these CaM-binding sites in mediating the Ca 2+ -dependent [14] and Ca 2+ -independent [18, 21] effects of CaM on IP 3 R behaviour have not been resolved [15, 26] and nor has the relationship between CaM and Ca 2+ -regulation of IP 3 R. A similar situation prevails for RyRs (ryanodine receptors), where neither the sites through which Ca 2+ biphasically regulates RyR gating nor the role of CaM are entirely resolved [27] . Ca 2+ -CaM and apo-CaM bind to overlapping sites on RyR1 (residues 3614-3643), probably via the C-lobe of CaM, whereas its N-lobe binds to a sequence (residues Abbreviations used: CaM, calmodulin; CLM, cytosol-like medium; DT40-IP 3 R1 (2-3), DT40 cells expressing only recombinant IP 3 R1 (2-3); DT40-KO, DT40 cells in which the genes for all of the IP 3 R subtypes have been disrupted; FBS, foetal bovine serum; GFP, green fluorescent protein; IBC, IP 3 1975-1999) on an adjacent RyR subunit [28] . RyR1 also has its own intrinsic CaM-like structure (residues 4064-4210), and this can bind to the C-lobe CaM-binding site [29] . Peptides derived from either region can interfere with activation of RyR suggesting that interactions between the CaM-like and CaM-binding domains might normally contribute to activation of RyR [29] [30] [31] . CaM itself might compete with these intra-receptor interactions. These observations from RyR, which are structurally and functionally related to IP 3 R, suggest that the perplexing effects of CaM on IP 3 R might in part reflect disruption of a similar interaction between an intrinsic CaM-like domain or tethered CaM, with CaM-binding sites on the IP 3 R. A recent report lent support to this suggestion by demonstrating that a CaM-binding peptide derived from MLCK (myosin light-chain kinase) massively inhibited IP 3 -evoked Ca 2+ release, leading the authors to conclude that endogenously bound CaM was required for activation of IP 3 R [32] . In the present study, we re-assess that interpretation and provide evidence that rather than causing dissociation of CaM from IP 3 R, MLCK peptide specifically disrupts the coupling of IP 3 binding to channel gating by binding directly to the N-terminal of the IP 3 R. MLCK peptide is a non-competitive antagonist of the IP 3 R that acts independently of CaM. We speculate that it disrupts an interdomain interaction between the SD (suppressor domain; residues 1-224 of IP 3 R) and IP 3 -binding core of the IP 3 R that is essential for receptor activation.
EXPERIMENTAL

Materials
Cell culture materials were from Gibco, except for FBS (foetal bovine serum; Sigma). CaM purified from bovine brain was from Calbiochem. All other reagents were from Sigma unless otherwise stated. The sequences of the peptides, their codes and suppliers are listed in Supplementary Table S1 at http://www. BiochemJ.org/bj/416/bj4160243add.htm.
Culture and transfection of DT40 cells
DT40 cells in which the genes for all three IP 3 R subtypes have been disrupted (DT40-KO) [33] and DT40 cells stably expressing only rat IP 3 R1 (GenBank ® accession number NP_001007236), mouse IP 3 R2 (GenBank ® accession number NP_112308) or rat IP 3 R3 (GenBank ® accession number NP_037270) (DT40-IP 3 R1-3 respectively) were grown in RPMI 1640 medium supplemented with 10 % FBS, 1 % heat-inactivated chicken serum, 2 mM L-glutamine and 50 μM 2-mercaptoethanol. Cells were grown in suspension in 175 cm 2 flasks at 37
• C in an atmosphere of 95 % air and 5 % CO 2 . They were used or passaged when they reached a density of ∼ 2 × 10 6 cells/ml.
Ca
2+ release from the intracellular stores of permeabilized cells
The Ca 2+ content of the intracellular stores of permeabilized cells was measured using a luminal low-affinity Ca 2+ indicator as previously reported [34] . Briefly, DT40 cells (4 × 10 7 cells/ml) were suspended in HBS [Hepes-buffered saline; 135 mM NaCl, 5.9 mM KCl, 11.6 mM Hepes, 1.5 mM CaCl 2 , 11.5 mM glucose and 1.2 mM MgCl 2 (pH 7.3)] containing 1 mg/ml BSA, 0.4 mg/ml Pluronic F127 and 20 μM Mag-fluo-4-AM (Invitrogen; where AM is acetoxymethyl ester). After incubation for 1 h at 20
• C in the dark with gentle shaking, cells were centrifuged (650 g for 2 min) and resuspended (10 7 (10 6 cells in 50 μl of CLM/well). After centrifugation of the plate (300 g for 2 min at 22
• C), fluorescence from the luminal indicator was recorded using a FlexStation (Molecular Devices) equipped to allow automated additions [34] . In all experiments, the intracellular stores were allowed to load to steady-state with Ca 2+ after addition of MgATP, and IP 3 was then added with 1 μM thapsigargin (to inhibit Ca 2+ reuptake).
Expression of NT (N-terminal) fragments of IP 3 R
The NT (residues 1-604) and IBC (IP 3 -binding core; residues 224-604) of IP 3 R1 were amplified by PCR from the full-length receptor clone lacking the S1 splice region. The S1 region was re-introduced using a QuikChange ® mutagenesis kit (Stratagene) [35] . The fragments were ligated into pTrcHis A (Invitrogen) to allow expression of N-terminally His 6 -tagged proteins in Escherichia coli strain BL21(DE3 [36] . Results were analysed by fitting to a four-parameter logistic equation (GraphPad Prism) from which the IC 50 and thereby the K D was calculated [18] .
Western blot analysis
Intact or permeabilized DT40 cells were prepared as for the Ca 2+ release assays and resuspended (8 × 10 7 cells/ml) in Ca 2+ -free CLM supplemented with protease inhibitors (Roche; one complete protease inhibitor mini-tablet/10 ml). The cells were lysed with 1 % (v/v) Triton X-100, three freeze-thaw cycles, and vigorous vortexing. Proteins were separated using SDS/PAGE pre-cast mini-gels (Invitrogen) and transferred on to a PVDF membrane using an Iblot dry-transfer apparatus (Invitrogen). The primary antibodies used were to CaM (monoclonal, 1:5000; Upstate) and to a peptide unique to the C-terminal of IP 3 R1 (rabbit, 1:1000) [37] . HRP (horseradish peroxidase)-conjugated secondary antibodies [anti-rabbit 1:5000 (AbCam) and anti-mouse 1:5000 (Promega)] and the Super Signal West Pico chemiluminescence reagent (Pierce) were used to detect immunoreactivity. Bands were quantified using GeneTools software (Syngene).
Immunoprecipitation
Permeabilized DT40-IP 3 R1 cells (10 8 cells) prepared as above were solubilized in 1 ml of lysis medium [140 mM NaCl, 10 mM Tris/HCl and one mini-protease inhibitor tablet/10 ml (pH 7.4)] containing 1 % (v/v) Triton X-100 at 4
• C for 1 h. After centrifugation (21 000 g at 4
• C for 15 min), the supernatant was incubated with the IP 3 R1 antiserum (1:1000) for 1 h at 4
• C on a rotating platform. Protein A/G-agarose plus beads (50 μl; Santa Cruz Biotechnology) were then added. After 12 h at 4
• C with constant rotation, the sample was centrifuged (650 g for 1 min) and washed five times in lysis medium containing 0.1 % Triton X-100. The pellet and supernatant fractions were characterized by Western blot analysis. Figure 1B ). It has been suggested that endogenous CaM may be pre-associated with IP 3 R [32] and perhaps thereby reduce the effects of added CaM. Permeabilized cells were pre-treated (100 μM for 10-20 min) with a Ca 2+ -CaM-binding peptide derived from MLCK (Supplementary Table S1 ) and then washed. Under these conditions, the inhibition by CaM of IP 3 -evoked Ca Table S1 ).
RESULTS AND DISCUSSION
The present and previous results [14, 32, 39] establish that Ca 2+ -CaM inhibits IP 3 -evoked Ca 2+ release by reducing the sensitivity of the intracellular stores to IP 3 , inhibition by added CaM appears not to be diminished by endogenously bound CaM, and the inhibition is reversed by a variety of CaM antagonists ( Figure 1C ).
Inhibition of all IP 3 R subtypes by MLCK peptide
In DT40-IP 3 R1 cells, MLCK peptide ( 100 μM) affected neither the Ca 2+ content of the intracellular stores nor their sensitivity (EC 50 ) to IP 3 , but the maximal response to IP 3 was significantly reduced (Figures 2A and 2B ). The inhibitory effect of a submaximal concentration of MLCK peptide (10 μM) was similar whether cells were pre-incubated with it for 2.5 min (40.6 + − 2.2 % inhibition, Supplementary Table S2 at Table S1 ) and which binds to Ca 2+ -CaM with > 10 6 -fold lower affinity [40] , was ineffective ( Figure 2C) . A scrambled MLCK peptide (MLCK S , 100 μM, Supplementary Table S1) was also ineffective ( Figure 2C ).
For most analyses of IP 3 -evoked Ca 2+ release, thapsigargin was added with IP 3 to allow the effects of IP 3 on unidirectional Ca 2+ release to be determined (see the Experimental section). To examine the kinetics of the effects of MLCK peptide, the experiments shown in Figure 2 (D) were performed without thapsigargin. The results demonstrate that addition of MLCK peptide (100 μM) after the stores have been emptied by IP 3 caused them rapidly to refill. The half-time (t 1/2 ) for this refilling (7.4 + − 0.3 s, n = 3) was indistinguishable from that of empty stores loading with Ca 2+ after the addition of ATP (7.6 + − 0.1 s, n = 3). These results establish that the time course of inhibition of IP 3 [32] . They differ, however, in that the inhibition was earlier reported to develop slowly (∼ 6 min), whereas in the present experiments inhibition was very rapid (< 8 s, Figure 2D ). It is, however, noteworthy that although Nadif Kasri et al. [32] observed a modest increase in the sensitivity to MLCK peptide when the incubation was extended from 2 to 6 min, they did not examine the effects of shorter incubations. Figure 3B ) by reducing the amount of Ca 2+ released. The latter was shown earlier [32] , as was inhibition of sea urchin IP 3 R by MLCK peptide, but the MLCK peptide has not hitherto been shown to inhibit homomeric IP 3 R2. It seems likely from these results that MLCK peptide inhibits all IP 3 R.
We Figures 4A and 4B ). An increase in cytosolic [Ca 2+ ] also increased the sensitivity of IP 3 R1 to inhibition by MLCK peptide ( Figure 4C ). The IC 50 for MLCK peptide decreased significantly as the cytosolic [Ca 2+ ] was increased without affecting the maximal inhibition (∼ 90 %). The Ca 2+ -sensitivity of the inhibition by MLCK peptide is consistent with its ability to bind selectively to Ca 2+ -CaM [41] , and consistent with the observation that MLCK peptide failed to inhibit IP 3 -evoked Ca 2+ release in Ca 2+ -free medium [32] . Camstatin (100 μM), a peptide that binds with high affinity to Ca 2+ -CaM and apoCaM [42] , had no effect on IP 3 -evoked Ca 2+ release; the latter despite camstatin reversing CaM inhibition of IP 3 -evoked Ca 2+ release ( Figure 1C ) and IP 3 binding [18] . These results contrast with the suggestion that peptides derived from CaM-binding sites of RyR1and IP 3 R1 inhibit IP 3 -evoked Ca 2+ release, although the inhibition by these peptides was far less than with MLCK peptide [32] . W-7 (20 μM), a non-peptide antagonist that binds only to Ca 2+ -CaM [43] , abolished the inhibition of IP 3 -evoked Ca 2+ release by CaM ( Figure 1C ), but alone it had no effect on IP 3 -evoked Ca 2+ release ( Figure 4D ). These results establish that not all effective inhibitors of CaM inhibit IP 3 MLCK peptide, before addition of MgATP and then IP 3 . The results demonstrate that the inhibition by MLCK peptide reverses completely when it is removed. Furthermore, a maximal or submaximal concentration of MLCK peptide evokes exactly the same inhibition of IP 3 -evoked Ca 2+ release whether added to naïve IP 3 R1 or those that have previously been fully inhibited by MLCK peptide ( Figure 5A ). These results contradict an earlier report [32] , in which inhibition by MLCK peptide did not reverse after its washout. It may be significant that our analysis involved more thorough washing steps. Furthermore, our results are incompatible with the suggestion that MLCK peptide causes inhibition of IP 3 R1 by promoting dissociation of bound CaM.
In both our experiments and those reported previously [32] , permeabilized cells were incubated in the absence of CaM for prolonged periods (∼ 20 min for the present study and ∼ 60 min for [32] ) with intervening washes before addition of IP 3 . Any CaM that remains associated with the IP 3 R must therefore dissociate extremely slowly. If MLCK peptide works by antagonizing the effect of CaM bound tightly to IP 3 R [32] , it is difficult to understand how CaM that remains tethered to IP 3 R for > 20 min after cell permeabilization can be released within 8 s of the addition of MLCK peptide ( Figure 2D ). We know of no precedent for Ca 2+ -CaM antagonists promoting CaM dissociation from its targets. The antagonists can only sequester Ca 2+ -CaM after it has dissociated and thereby prevent its reassociation [40] . Under these circumstances, it seems improbable that residual CaM tightly associated with most IP 3 R could dissociate within 8 s ( Figure 2D ; or 2 min [40] ) of the addition of MLCK peptide.
The results so far are not consistent with MLCK peptide displacing CaM from a simple CaM-binding site on the IP 3 R, but they leave open the possibility that a more complex tethering of CaM, such as occurs with RyR1 [28, 44] or voltage-gated Ca 2+ channels [45] , where each lobe of CaM is separately anchored to its target, might be disrupted by MLCK peptide. Subsequent experiments eliminated this possibility.
CaM is not tethered to IP 3 R1
Most endogenous CaM (98.5 + − 0.8 %, Figure 5B ) or heterologously expressed GFP (green fluorescent protein, 30 kDa; results not shown) was released from DT40 cells when they were permeabilized. Furthermore, heparin (13.5-15 kDa), a competitive antagonist of IP 3 [36] , caused the expected concentrationdependent (K D = 15 μg/ml, from Schild analysis) inhibition of IP 3 -evoked Ca 2+ release from permeabilized DT40 cells (results not shown). These results establish that free CaM is not retained by permeabilized cells and that exogenous CaM and other molecules of similar (heparin) or larger size (GFP) can reach the intracellular stores ( Figures 1B and 1C) . However, these results do not exclude the possibility that some CaM remains tethered within cells.
After permeabilization of DT40-IP 3 R1 cells under conditions identical with those used for Ca 2+ -release assays, we detected 4000 + − 320 tetrameric IP 3 R/cell and 4500 + − 700 molecules of CaM/cell ( Figures 5B and 5C ). Similar amounts of CaM (4990 + − 1100 molecules/cell) were associated with permeabilized DT40-KO cells that lack IP 3 R. The density of IP 3 with IP 3 R1 after immunoprecipitation of IP 3 R1 ( Figure 5D ). The supernatant contained 113 + − 10 % of the CaM detected in the cell lysate, and the immunoprecipitate contained 29 + − 1.5 fmol of IP 3 R1 ( Figure 5D ) and < 5.9 fmol of CaM (the sensitivity threshold of our Western blot for CaM). These results establish that CaM is not stoichiometrically tethered to IP 3 R. We conclude that inhibition of IP 3 -evoked Ca 2+ release by MLCK peptide results from neither complete dissociation of CaM from IP 3 R nor reversible displacement of tethered CaM from an essential binding site.
An endogenous CaM-like region of IP 3 R1, F2v, does not mediate the effects of MLCK peptide
Another possibility is that MLCK peptide might bind to an endogenous CaM-like structure within the IP 3 R, analogous to the CaM-like structure within RyR [29] , although even this interaction would not alone provide an obvious explanation for the inability of other CaM antagonists to reproduce the effects of MLCK peptide. A protein-fold prediction program (3D-PSSM, http://www.sbg.bio.ic.ac.uk/3dpssm) that identified the CaM-like domain of RyR1 [29] failed to identify any EF-hand-like motifs in any of the rat IP 3 R subtypes. Nor was there any significant sequence similarity between the CaM-like domains of RyR and the equivalent region immediately before the transmembrane domains of IP 3 R.
A C-terminal region (CIRB domain) of the TRPC3 protein (Ser 764 -Asp 793 ) and of other TRPC proteins binds both Ca 2+ -CaM and an N-terminal region of all three IP 3 R subtypes ( Figure 6A ), such that Ca 2+ -CaM and IP 3 R compete for binding to the CIRB domain [46] . Ca 2+ -CaM and the isolated peptides from IP 3 R3 (F2v: Glu 681 -Asp 698 ) [47] and TRPC3 (CIRB3: Ser 764 -Asp 793 ) interact directly [46] . These observations suggest that residues 684-702 of IP 3 R1 may, at least insofar as they are recognized by TRPC proteins, mimic CaM ( Figure 6A ), although the sequence itself has no obvious resemblance to CaM. We therefore considered the possibility that this region (684-702) of IP 3 R1 might be the site through which MLCK peptide causes inhibition of IP 3 -evoked Ca 2+ release. However, CIRB3 ( 30 μM) had no effect on the fraction of the Ca 2+ stores released by a maximal concentration of IP 3 ( Figure 6B ), although it did reduce the steadystate loading of the Ca 2+ stores. We have not explored the latter further, but it is noteworthy that F2v peptide (100 μM), the fragment of IP 3 R3 that competes with CaM for binding to CIRB3, fully reversed the inhibition of Ca 2+ uptake by CIRB3 (30 μM) ( Figure 6B ). This suggests that the peptides interact appropriately with each other [46] . Nevertheless, F2v has no effect on the ability of MLCK peptide to inhibit IP 3 -evoked Ca 2+ release ( Figure 6B ). We conclude that it is unlikely that MLCK peptide inhibits IP 3 R by interacting with the site through which IP 3 R competes with CaM for binding to the CIRB domain of TRPC proteins. Figure 7A ). This is consistent with previous analyses of cerebellar microsomes, although the same study reported that MLCK peptide did not affect [ 3 H]IP 3 binding to recombinant IP 3 R1 [32] . However, the single high concentration of [ 3 H]IP 3 used (10 nM) for the latter experiments may have obscured any modest increase in the affinity of IP 3 R1 (K D for IP 3 = 9.6 + − 1.9 nM under the conditions used [37] ).
MLCK peptide also stimulated IP 3 binding to the NT fragment (residues 1-604) of IP 3 R1 (Figures 7A-7D ), but not to the IBC (residues 224-604) alone ( Figure 7A ). The MLCK C and MLCK S peptides were ineffective ( Figure 7C ). The effect of MLCK peptide was due entirely to an increase in the affinity of the NT for IP 3 : the K D for IP 3 was 29 + − 6 nM in the presence of 30 μM MLCK peptide, and 53 + − 10 nM in its absence ( Figure 7B ). CaM (10 μM) modestly inhibited specific binding of [ 3 H]IP 3 to the NT ( Figure 7C ), consistent with a previous report [10] . In keeping with results from the functional assays ( Figures 1C  and 2 ), other CaM antagonists (CIRB3, camstatin and W-7) had no effect on specific Figure 7D ) and of IP 3 -evoked Ca 2+ release (IC 50 = 20 + − 4 μM, Figure 2C ) were indistinguishable. These results with the bacterially expressed NT of IP 3 R1 confirm that MLCK peptide interacts directly and specifically with IP 3 R1 in the complete absence of CaM.
MLCK peptide selectively uncouples IP 3 binding from channel gating
We have confirmed that MLCK peptide massively inhibits IP 3 -evoked Ca 2+ release via each of the three IP 3 R subtypes [32] (Figures 2 and 3) . Other antagonists that effectively reverse the effects of exogenous CaM do not mimic MLCK peptide (Figures 1C and 4D) , the inhibition by MLCK peptide is very rapid ( Figure 2D ) and it is entirely independent of CaM ( Figures 4D, 5 and 7). The inhibition is specific in that is not mimicked by other CaM antagonists, by a scrambled MLCK peptide (MLCK S ) or by a peptide (MLCK C peptide) that differs by only two residues from MLCK peptide ( Figures 2C, 2D, 7C and Supplementary  Table S1 ). We conclude that endogenously bound CaM is not essential for activation of IP 3 R [32] , but that MLCK peptide directly interacts with the NT of the IP 3 R to uncouple IP 3 binding from channel gating.
MLCK peptide stimulates IP 3 binding only when the SD is present ( Figure 7A ). This is significant because the SD is required for activation of IP 3 R [48] , possibly by providing the link between IP 3 binding to the IBC and the cytosolic loop linking TMD (transmembrane domains) 4 and 5 that may directly gate the channel [49, 50] . Because some of the free energy provided by binding of IP 3 to the IBC is used to evoke the conformational changes that lead to channel gating, disrupting the conformational changes can lead to an increase in IP 3 affinity (A. M. Rossi, and C. W. Taylor, unpublished work). One such example, is the increase in IP 3 affinity associated with removal of the SD [51, 52] and another is provided by the demonstration that disruption of the TMD4-5 loop increases IP 3 affinity [50] . We speculate that MLCK peptide disrupts effective communication between the IBC and SD and thereby prevents IP 3 from diverting its binding energy into the conformational changes that lead to channel opening, causing both an increase in IP 3 affinity and a loss of channel gating by IP 3 ( Figure 8A ). But why should MLCK peptide so selectively disrupt IP 3 R activation?
Binding of MLCK peptide to CaM [41] occurs via a well characterized positively charged α-helical '1-8-14' CaM-binding motif [53] , where the numbers denote the positions of conserved hydrophobic/aromatic residues ( Figures 8B and 8C) . By sequence alignment and manual inspection, we identified a similar sequence within the first apo-CaM-binding site of rat IP 3 R1(residues 50-82) [10] (Figure 8B ). The sequence (residues 51-66), which is conserved in all IP 3 R (Figure 8B ), retains the critical arrangement of hydrophobic residues, it has the same propensity as MLCK peptide to form an α-helix (http://calcium.uhnres.utoronto.ca) and the predicted orientations of the key hydrophobic and basic residues are similar for both peptides (Figures 8C and 8D) . None of the inactive peptides retains the 1-8-14 motif. MLCK C peptide has two of the key hydrophobic residues replaced by a glutamate residue (Supplementary Table S1 ) and camstatin and CIRB bind to CaM via an 'IQ motif' and '1-5-10 motif' respectively [53] . We note also that the CaM-binding peptide derived from RyR1, which rather ineffectively inhibited IP 3 R [15] , has appropriate hydrophobic residues at positions 1 and 14, but position 8 is occupied by a basic residue (lysine). In isolation, the putative 1-8-14 peptide from IP 3 R1 is predicted to be α-helical ( Figure 8C ), but within the SD it is not α-helical. It is, however, striking that within this native setting the positions of the key hydrophobic residues replicate those within MLCK peptide ( Figure 8D ).
We speculate that the intrinsic pseudo 1-8-14 motif within the SD of all IP 3 R plays an essential role in facilitating communication between the IBC and pore. One possibility is that CaM may bind directly to this motif [10] , whereas MLCK peptide may bind to an endogenous site (as yet unidentified) that shares some critical features with CaM and which normally interacts with the 1-8-14 motif. By analogy with similar interdomain interactions within RyR [31] , we suggest that both CaM and MLCK peptide may [50] . We suggest that MLCK peptide binds directly to the SD, uncoupling its interaction with the IBC, and so causing both an increase in IP 3 affinity and a loss of IP 3 -gated channel activity. (B) Within the SD of all IP 3 R, there is a sequence in which the essential features of a 1-8-14 CaM-binding motif [53] are conserved. The essential and appropriately spaced (1-8-14) hydrophobic/aromatic residues are highlighted in blue. A net positive charge (+3 to +6) provided by basic residues (red) is another key feature of the motif. 'unzip' an essential interaction between two domains that are required for IP 3 R activation ( Figure 8F ). We recognize that our scheme is presently too simple because MLCK peptide and CaM do not have identical inhibitory effects, but the differences may arise from additional sites of interaction between CaM and the IP 3 R [10] . Our interpretation is, however, consistent with the effects of mutations within the SD (highlighted in Figure 8E ) that interfere with communication between the IBC and SD [51] . These residues form a continuous surface with the putative 1-8-14 motif.
We conclude that MLCK peptide is a non-competitive antagonist of all IP 3 R that acts entirely independently of CaM to uncouple IP 3 binding from channel gating. We speculate that MLCK peptide mimics a motif within the SD that resembles a 1-8-14 CaM-binding motif and thereby 'unzips' an interdomain interaction (possibly between the SD and IBC) that is essential for IP 3 R activation. Our results emphasize the importance of the SD in IP 3 R activation and suggest that MLCK peptide may provide a route to novel, non-competitive antagonists of IP 3 R. 
